該雜志國際簡稱:DRUG METAB DISPOS,是由出版商American Society for Pharmacology and Experimental Therapeutics出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以PHARMACOLOGY & PHARMACY研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。
基本信息:
期刊簡稱:DRUG METAB DISPOS
是否OA:未開放
是否預(yù)警:否
Gold OA文章占比:18.86%
出版信息:
出版地區(qū):UNITED STATES
出版周期:Monthly
出版語言:English
出版商:American Society for Pharmacology and Experimental Therapeutics
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism[S]
Author: Koubek, Emily J.; Buhrow, Sarah A.; Safgren, Stephanie L.; Jia, Lee; Goetz, Matthew P.; Ames, Matthew M.; Reid, Joel M.
Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor Profiles
An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.